If you’re in a hurry, please just check out this outstanding new trading system now!

In case you hadn’t noticed, markets around the world are in TURMOIL.

The global economy is getting worse by the day…

Perhaps you’ve even seen your own stock portfolio or retirement account take a beating this week.

Here’s the good news:

You DON’T have to be a victim, and you DON’T have to sit around and watch your net worth continue to shrink!

I received an email from the owners of the TradingPro System who tell me that a very small number of “elite” traders are making a FORTUNE from the market right now. They know a “secret” way of trading that enables them to make a killing from the market, regardless of whether it goes up or down.

Less than 1% of all traders understand this method, and virtually NO ONE is teaching it.

HUGE, new opportunity today!

This …

Vanda Pharma (VNDA) and Titan Pharma (TTP) are a pair of biotech blow-ups which investors should avoid ahead of a July 27, 2008, PDUFA decision date for anti-psychotic drug Fanapta (iloperidone). Both stocks have lost about two-thirds of their market value over the last year and are down sharply recently on pipeline clinical trial failures. I don’t think the FDA will approve Fanapta as the anti-psychotic space already has plenty of similar options and thec agency is cracking down on the widespread, off-label use of these drugs in elderly patients.

In the CNBC.com video “Go Short” how does Options University strategist Ron Ianieri define a “speculator”?

“Everyone who is in the market.”

In “What Options are Saying about Lehman” Rebecca Darst said “the question…on everyone’s lips” is whether there is a

“The question, I think, on everyone’s lips is whether we’re seeing a Bear Stearns-like setup in Lehman Brothers,” said Rebecca Darst of Interactive Brokers on CNBC’s “Squawk Box.”

I’m still avoiding Lehman Brothers (LEH).